Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations (Q24597375)

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Innovative use of topical calcineurin inhibitors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Association between exposure to topical tacrolimus or pimecrolimus and cancers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Black box warning for topical calcineurin inhibitors and the death of common sense.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Adverse effects of topical glucocorticosteroids

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Clinical practice. Atopic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3715696

Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence

27 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40272-013-0013-9

Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40272-013-0013-9

Validity of the codes of suicidality in the THIN database

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40272-013-0013-9

21 January 2018

1 reference

12 December 2020

Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis

1 reference

12 December 2020

Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults

1 reference

12 December 2020

Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas

1 reference

12 December 2020

1 reference

12 December 2020

Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns

1 reference

12 December 2020

10.1007/S40272-013-0013-9

Identifiers

DOI

1 reference

Dimensions Publication ID

1001363622

0 references

Fatcat ID

release_fglainro4zezfm24466ahhyhem

0 references

1 reference

1 reference

PubMed publication ID

23549982

1 reference